T. Shaw3, L., Hariprasad, I., V. Messner, L., A. Bansal, C., A. Schechet, S. and Pérez, J. (2022) “Topical Nepafenac 0.1% or 0.3% for the Treatment of Central Serous Chorioretinopathy: A Case Series of Chronic and Recurrent Disease and Review of the Literature”, BOHR International Journal of Current Research in Optometry and Ophthalmology, 1(1), pp. 74–79. doi: 10.54646/bijcroo.2022.19.